Microplastics are everywhere, but are they harming us?Evidence suggests they might, but it's limited in scope. Some researchers are worried, but acknowledge there are lots of unanswered questions. A year after launch: How are B.C. pharmacists integrating minor ailments? Pharmacists in B.C. have had the ability to prescribe and treat for 21 minor ailments as well as for contraception since June 1, 2023. Part one: Should transgender athletes compete with their cis counterparts? What are the parameters that need to be considered to make a good-faith assessment of the question? Breast cancer drugs could fight prostate cancer The effectiveness of androgen-targeted treatments for prostate cancer tends to fade over time, so new strategies are urgently needed. JULY UPDATE: New indications for six drugs prescribers and pharmacists should know about Check out these new indications for six drugs as part of our July drug news roundup. Doctors excited about targeted prostate cancer therapy, but can’t prescribe it yet Dale Cousins is part of a clinical trial of radioligand therapy, or RLT—a precise targeting of cancer cells with radiation given intravenously. Patients showing up with green hair? You might be able to blame it on an anesthetic. Low testosterone in men associated with an early death: new study It has long been thought that testosterone shortens men’s lives. However, a new meta-analysis draws these findings into question. Safety of combining PDE5 inhibitors and nitrates Some studies have demonstrated lower mortality with phosphodiesterase-5 inhibitor treatment for erectile dysfunction in men with stable coronary artery disease, compared with no treatment. Breaking the cycle: A pharmacist’s guide to prevention and management of recurrent UTIs in women Up to 50% to 60% of women will have a urinary tract infection in their lifetime, and up to 25% to 30% of these women will have a recurrent UTI. First Previous 4 5 6 7 8 Next Last
